Bücher Wenner
Vorlesetag - Das Schaf Rosa liebt Rosa
15.11.2024 um 15:00 Uhr
Communicating Therapeutic Risks
von Louis A. Morris
Verlag: Springer New York
Reihe: Recent Research in Psychology
Hardcover
ISBN: 978-0-387-97192-6
Auflage: Softcover reprint of the original 1st ed. 1990
Erschienen am 21.12.1989
Sprache: Englisch
Format: 235 mm [H] x 155 mm [B] x 12 mm [T]
Gewicht: 312 Gramm
Umfang: 200 Seiten

Preis: 106,99 €
keine Versandkosten (Inland)


Dieser Titel wird erst bei Bestellung gedruckt. Eintreffen bei uns daher ca. am 21. November.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

106,99 €
merken
zum E-Book (PDF) 96,29 €
klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Inhaltsverzeichnis

I guess everyone has a cousin Ernest. He is the fellow of whom your mother asks . . . "Why can't you be more like your cousin Ernest?" Cousin Ernest went to the high school for genius children and got all A's, even in French. As the years went by, I lost contact with Cousin Ernest. Then last year, at a family gathering, I met him again. Sure enough, he had gone to Harvard and become a doctor, a radiologist. We began discussing his practice and he mentioned that he performs some fairly risky diagnostic tests. While legally he was compelled to tell patients about the risks they were undertaking, he said that risk disclosure was a useless exercise. "No one has ever refused to undergo the procedure," he said. It was difficult to argue with his observation that no patient ever refused to undergo his tests. I understood that the lack of refusals did not necessarily mean that risk disclosure was a useless exercise, but his underlying argument was quite compelling.



1. Introduction.- 2. Learning About Therapy.- Why Communicate Risks? - The Health Professional Perspective.- Why Communicate Risks? - The Patient Perspective.- Motivation to Seek Risk Information.- The Content of Risk Communication.- Sources of Risk Information.- Stimulating Risk Disclosure.- Implications.- 3. Physician's Risk Disclosure.- Normative Studies of Doctor-Patient Communication.- Information Exchange Standards.- Risk Disclosure Factors.- Moderating Factors - The Physician.- Moderating Factors - The Prescribing Environment.- Implications.- 4. Patient Information Processing.- Attention to Risk Information.- Comprehension.- Integration in Memory.- Processing Risk Communications.- Information Retrieval.- Implications.- 5. Patients' Medical Judgments.- The Patient as a Decision Maker.- Biases in Decision Making.- Patient Consent and Risk Acceptance.- Risk Communication and Compliance.- Implications.- 6. Effects of Risk Communication.- The Initial Doctor Visit.- Product Use.- Treatment Evaluation.- Maintaining Treatment.- Implications.- 7. Mass Media Risk Communication.- Historical Development of PPIs.- Assessment of PPI Effects.- Direct Advertising of Prescription Drugs.- Risk Disclosure in Television and Magazines.- Implications.- References.


andere Formate
weitere Titel der Reihe